Value of dual contrast liver MRI at 3.0 T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules: Preliminary results of multivariate analysis

Investigative Radiology

Volumn 44, Issue 10, 2009, Pages 641-649

  Yoon, Min A ^a   Kim, Se Hyung ^a   Park, Hee Sun ^b   Lee, Dong Ho ^a   Lee, Jae Young ^a   Han, Joon Koo ^a   Choi, Byung Ihn ^a  

^a Seoul National University Hospital   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

Dysplastic nodule; Hepatocellular carcinoma; Magnetic resonance imaging

Indexed keywords

GADOLINIUM; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIATION; DYSPLASTIC NODULE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOLOGIST;

EID: 70349667172     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181ab6e57     Document Type: Article

References (24)

1. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepato-carcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol. 1991;22:172-178.
2. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 1992;15: 948-963.
3. Earls JP, Theise ND, Weinreb JC, et al. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology. 1996;201:207-214.
4. Li CS, Chen RC, Tu HY, et al. Imaging well-differentiated hepatocellular carcinoma with dynamic triple-phase helical computed tomography. Br J Radiol. 2006;79:659-665.
5. Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxide- enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology. 2000;32:205-212.
6. Choi SH, Lee JM, Yu NC, et al. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. Am J Roentgenol. 2008;191:529-536.
7. Krinsky GA, Lee VS, Theise ND, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology. 2001;219:445-454.
8. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
9. Lee DH, Kim SH, Lee JM, et al. Diagnostic performance of MDCT, SPIO-enhanced MRI, and dual-contrast MRI in predicting the appropriateness of a transplant recipient based on Milan criteria: correlation with histopathological findings. Invest Radiol. 2009;44:311-321.
10. Kim SH, Choi BI, Lee JY, et al. Diagnostic accuracy of multi-/single-detector row CT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the Milan criteria before liver transplantation. Intervirology. 2008;51(suppl 1):52-60.
11. Park HS, Lee JM, Kim SH, et al. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0-Tesla. J Magn Reson Imaging. 2009;29:328-335.
12. Ward J, Guthrie JA, Scott DJ, et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology. 2000;216:154-162.
13. Schick F. Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol. 2005;15:946-959.
14. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983-993.
15. Tajima T, Honda H, Taguchi K, et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. Am J Roentgenol. 2002;178:885-897.
16. Asayama Y, Yoshimitsu K, Nishihara Y, et al. Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. Am J Roentgenol. 2008;190:W28-W34.
17. Yukisawa S, Okugawa H, Masuya Y, et al. Multidetector helical CT plus superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions in cirrhotic liver: a comparison with multi-phase CT during hepatic arteriog-raphy. Eur Radiol. 2007;61:279-289.
18. Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. Am J Roentgenol. 1999;172:969-976.
19. Bhartia B, Ward J, Guthrie JA, et al. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. Am J Roentgenol. 2003;180:577-584.
20. Yoo HJ, Lee JM, Lee MW, et al. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation. Invest Radiol. 2008;43:538-546.
21. Gandhi SN, Brown MA, Wong JG, et al. MR contrast agents for liver imaging: what, when, how. Radiographics. 2006;26:1621-1636.
22. Cavagna FM, Maggioni F, Castelli PA, et al. Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol. 1997;32:780-796.
23. Kim JI, Lee JM, Choi JY, et al. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Invest Radiol. 2008;43:202-210.
24. Zech CJ, Grazioli L, Breuer J, et al. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol. 2008;43:504-511.